Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

20.01

+0.41 (2.09%)

At close: Nov 2, 2026, 4:00 PM EST

20.01

0.00 (0.00%)

After-hours: Nov 2, 2026, 4:33 PM EST

Seaport Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	59.04	20.98	27.35
Research & Development	89.96	64.42	25.07
Operating Expenses	149	85.4	52.42
Operating Income	-149	-85.4	-52.42
Interest & Investment Income	11.4	11.4	5.54
Other Non Operating Income (Expenses)	-2.96	-3.55	-
EBT Excluding Unusual Items	-140.56	-77.54	-46.88
Gain (Loss) on Sale of Investments	3.43	3.43	-
Pretax Income	-137.13	-74.11	-46.88
Income Tax Expense	1.41	0.77	-
Net Income	-138.54	-74.88	-46.88
Net Income to Common	-138.54	-74.88	-46.88
Net Income Growth	-	-	-
Shares Outstanding (Basic)	29	7	3
Shares Outstanding (Diluted)	29	7	3
Shares Change	1101.91%	151.76%	-
EPS (Basic)	-4.82	-10.04	-15.83
EPS (Diluted)	-4.82	-10.04	-15.83
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-	-78.3	-29.74
Free Cash Flow Per Share	-	-10.50	-10.04
EBITDA	-148.87	-85.22	-52.25
D&A For EBITDA	0.13	0.17	0.17
EBIT	-149	-85.4	-52.42

SEC Filings: 10-K · 10-Q